Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
CA 2526595 C · Owner: Valle, Fernando · Inventors: Kumar, Manoj; Valle, Fernando; Rashid, M. Harunur
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to engineering metabolic pathways in bacterial host cells which results in enhanced carbon flow for the production of ascorbic acid (ASA) intermediates. In particular the invention relates to , increasing the production of ASA intermediates in bacterial cells by enhancing the availability of gluconate resulting from the inactivation of endogenous gluconate transporter genes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 10, 2004 and granted October 7, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 10, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 10, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.